Literature DB >> 25328532

Micromanaging microRNAs: using murine models to study microRNAs in lung fibrosis.

Christian L Lino Cardenas1, Naftali Kaminski1, Daniel J Kass1.   

Abstract

MicroRNAs are implicated in many biological and pathological processes and are emerging as key actors in lung health and disease. Specific patterns of dysregulated microRNAs have been found in idiopathic pulmonary fibrosis (IPF), an untreatable interstitial lung disease of unknown etiology. IPF is characterized by dramatic and extensive phenotypic changes in the lung that include alveolar cell hyperplasia, fibroblast proliferation and formation of myofibroblast foci, deposition of extracellular matrix, and changes in lung transcriptional programming. Here, we discuss the latest insights about the role of microRNAs in lung fibrosis with a focus on the contribution of animal models of disease to the derivation of these insights.

Entities:  

Year:  2013        PMID: 25328532      PMCID: PMC4201640          DOI: 10.1016/j.ddmod.2012.11.003

Source DB:  PubMed          Journal:  Drug Discov Today Dis Models        ISSN: 1740-6757


  39 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.

Authors:  Yan Zeng; Rui Yi; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

3.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

4.  Genetic linkage analysis of pulmonary fibrotic response to silica in mice.

Authors:  Y Ohtsuka; X-T Wang; J Saito; T Ishida; M Munakata
Journal:  Eur Respir J       Date:  2006-07-12       Impact factor: 16.671

5.  miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice.

Authors:  Jun Xiao; Xiao-Ming Meng; Xiao R Huang; Arthur Ck Chung; Yu-Lin Feng; David Sc Hui; Cheuk-Man Yu; Joseph Jy Sung; Hui Y Lan
Journal:  Mol Ther       Date:  2012-03-06       Impact factor: 11.454

Review 6.  MicroRNA biogenesis: isolation and characterization of the microprocessor complex.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Ramin Shiekhattar
Journal:  Methods Mol Biol       Date:  2006

7.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Genes Dev       Date:  2007-04-16       Impact factor: 11.361

8.  Perflubron enhances adenovirus-mediated gene expression in lungs of transgenic mice with chronic alveolar filling.

Authors:  D J Weiss; T P Strandjord; D Liggitt; J G Clark
Journal:  Hum Gene Ther       Date:  1999-09-20       Impact factor: 5.695

Review 9.  Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair.

Authors:  Paul W Finch; Jeffrey S Rubin
Journal:  Adv Cancer Res       Date:  2004       Impact factor: 6.242

10.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

View more
  9 in total

1.  Nicotine Modulates Growth Factors and MicroRNA to Promote Inflammatory and Fibrotic Processes.

Authors:  Afshin Ebrahimpour; Samana Shrestha; Mark D Bonnen; N Tony Eissa; Ganesh Raghu; Yohannes T Ghebre
Journal:  J Pharmacol Exp Ther       Date:  2018-11-16       Impact factor: 4.030

Review 2.  Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms.

Authors:  Francisco Paulin; Tracy J Doyle; Elaine A Fletcher; Dana P Ascherman; Ivan O Rosas
Journal:  Rev Invest Clin       Date:  2015 Sep-Oct       Impact factor: 1.451

Review 3.  Integrating omics technologies to study pulmonary physiology and pathology at the systems level.

Authors:  Ravi Ramesh Pathak; Vrushank Davé
Journal:  Cell Physiol Biochem       Date:  2014-04-28

4.  MicroRNA let-7 Downregulates Ligand-Independent Estrogen Receptor-mediated Male-Predominant Pulmonary Fibrosis.

Authors:  Sharon Elliot; Simone Periera-Simon; Xiaomei Xia; Paola Catanuto; Gustavo Rubio; Shahriar Shahzeidi; Fadi El Salem; Josh Shapiro; Karoline Briegel; Kenneth S Korach; Marilyn K Glassberg
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

5.  Baicalin relieves Mycoplasma pneumoniae infection‑induced lung injury through regulating microRNA‑221 to inhibit the TLR4/NF‑κB signaling pathway.

Authors:  Han Zhang; Xiang Li; Juan Wang; Qi Cheng; Yunxiao Shang; Guizhen Wang
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

6.  1α,25-Dihydroxyvitamin D3 prevents the differentiation of human lung fibroblasts via microRNA-27b targeting the vitamin D receptor.

Authors:  Fei Li; Aizhen Zhang; Yiwei Shi; Yuehong Ma; Yongcheng Du
Journal:  Int J Mol Med       Date:  2015-08-20       Impact factor: 4.101

7.  MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasia.

Authors:  Yujiao Xing; Jianhua Fu; Haiping Yang; Li Yao; Lin Qiao; Yanna Du; Xindong Xue
Journal:  Int J Mol Med       Date:  2015-09-17       Impact factor: 4.101

8.  microRNA-186 in extracellular vesicles from bone marrow mesenchymal stem cells alleviates idiopathic pulmonary fibrosis via interaction with SOX4 and DKK1.

Authors:  Jing Zhou; Yang Lin; Xiuhua Kang; Zhicheng Liu; Wei Zhang; Fei Xu
Journal:  Stem Cell Res Ther       Date:  2021-02-03       Impact factor: 6.832

9.  Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study.

Authors:  Stefano Di Carlo; Elena Rossi; Gianfranco Politano; Simona Inghilleri; Patrizia Morbini; Fiorella Calabrese; Alfredo Benso; Alessandro Savino; Emanuela Cova; Davide Zampieri; Federica Meloni
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.